Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Süreyya Bozkurt, Tülin Özkan, Füsun Özmen, Yusuf Baran, Asuman Sunguroğlu & Emin Kansu. (2013) The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells. Hematology 18:4, pages 217-223.
Read now
Read now
Geylani Can, Huseyin Atakan Ekiz & Yusuf Baran. (2011) Imatinib induces autophagy through BECLIN‐1 and ATG5 genes in chronic myeloid leukemia cells. Hematology 16:2, pages 95-99.
Read now
Read now
Buket Kosova, Burcin Tezcanli, Huseyin Atakan Ekiz, Zeynep Cakir, Nur Selvi, Aysegul Dalmizrak, Melis Kartal, Ufuk Gunduz & Yusuf Baran. (2010) Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells. Leukemia & Lymphoma 51:10, pages 1895-1901.
Read now
Read now
Yusuf Baran, Coskun Oztekin & Esen Yonca Bassoy. (2010) Combination of Fludarabine and Imatinib Induces Apoptosis Synergistically Through Loss of Mitochondrial Membrane Potential and Increases in Caspase-3 Enzyme Activity in Human K562 Chronic Myleloid Leukemia Cells. Cancer Investigation 28:6, pages 623-628.
Read now
Read now
Huseyin Atakan Ekiz, Geylani Can, Ufuk Gunduz & Yusuf Baran. (2010) Nilotinib significantly induces apoptosis in imatinib resistant K562 cells with wild-type BCR–ABL, as effectively as in parental sensitive counterparts. Hematology 15:1, pages 33-38.
Read now
Read now
Gozde Gucluler & Yusuf Baran. (2009) Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells. Hematology 14:3, pages 139-144.
Read now
Read now
Articles from other publishers (22)
Petr Mlejnek. (2023) What Is the Significance of Lysosomal-Mediated Resistance to Imatinib?. Cells 12:5, pages 709.
Crossref
Crossref
Yılmaz UĞUR, Emine ŞALVA, Fırat KARAAT & Selim ERDOĞAN. (2023) Antiproliferative properties and evaluation of antioxidant of different cornelian cherry genotypes and analysis of phenolic and sugar compounds by HPLC. Hacettepe Journal of Biology and Chemistry 51:1, pages 57-70.
Crossref
Crossref
Kartini Asari, Wen Tian Sun, Ze Hui Kok, Yi Hui Lam, Bee Ling Ng, Verity Saunders, Deborah L. White, Charles Chuah & Wei Xiang. (2021) Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation. Anti-Cancer Drugs 32:5, pages 526-536.
Crossref
Crossref
Hanbo Cao, Wenjun Li, Yizhou Zhou, Renxiang Tan, Yue Yang, You Zhou, Qinglong Guo & Li Zhao. (2019) Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway. Frontiers in Oncology 9.
Crossref
Crossref
Hasan Hüseyin Kazan, Cagri Urfali-Mamatoglu & Ufuk Gündüz. (2017) Resistance to anticancer drugs permanently alters electrophoretic mobility of cancer cell lines. ELECTROPHORESIS 38:8, pages 1201-1205.
Crossref
Crossref
Ying-Jung Chen & Long-Sen Chang. (2015) NFκB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-α-treated human leukemia U937 cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1849:10, pages 1248-1259.
Crossref
Crossref
Yağmur Demircan, Aziz Koyuncuoğlu, Murat Erdem, Ebru Özgür, Ufuk Gündüz & Haluk Külah. (2015) Label-free detection of multidrug resistance in K562 cells through isolated 3D-electrode dielectrophoresis. ELECTROPHORESIS 36:9-10, pages 1149-1157.
Crossref
Crossref
Ying-Jung Chen & Long-Sen Chang. (2014) Simvastatin induces NFκB/p65 down-regulation and JNK1/c-Jun/ATF-2 activation, leading to matrix metalloproteinase-9 (MMP-9) but not MMP-2 down-regulation in human leukemia cells. Biochemical Pharmacology 92:4, pages 530-543.
Crossref
Crossref
Wen-Hsin Liu, Ying-Jung Chen, Jen-Hung Chien & Long-Sen Chang. (2014) Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in human leukemia cells. Journal of Cellular Physiology 229:5, pages 588-598.
Crossref
Crossref
Garsha Bahrieh, Murat Erdem, Ebru Özgür, Ufuk Gündüz & Haluk Külah. (2014) Assessment of effects of multi drug resistance on dielectric properties of K562 leukemic cells using electrorotation. RSC Adv. 4:85, pages 44879-44887.
Crossref
Crossref
Vanessa Augis, Kelly Airiau, Marina Josselin, Béatrice Turcq, François-Xavier Mahon & Francis Belloc. (2013) A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib. PLoS ONE 8:11, pages e78582.
Crossref
Crossref
Yusuf Baran, Cagatay Ceylan & Aylin Camgoz. (2013) The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy. Biomedicine & Pharmacotherapy 67:3, pages 221-227.
Crossref
Crossref
Jun Lee, Peiqiang Shen, Guobing Zhang, Xiuhua Wu & Xingguo Zhang. (2013) Dihydroartemisinin inhibits the Bcr/Abl oncogene at the mRNA level in chronic myeloid leukemia sensitive or resistant to imatinib. Biomedicine & Pharmacotherapy 67:2, pages 157-163.
Crossref
Crossref
Wen-Hsin Liu, Yeh-Long Chen & Long-Sen Chang. (2012) CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability. The International Journal of Biochemistry & Cell Biology 44:12, pages 2212-2222.
Crossref
Crossref
Paloma Silva de Souza, Flavia da Cunha Vasconcelos, Luis Felipe R. Silva & Raquel Ciuvalschi Maia. (2012) Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells. Tumor Biology 33:4, pages 943-956.
Crossref
Crossref
Zhu Xishan, An Guangyu, Song Yuguang & Zhang Hongmei. (2011) The research on the immuno-modulatory defect of Mesenchymal Stem Cell from Chronic Myeloid Leukemia patients. Journal of Experimental & Clinical Cancer Research 30:1.
Crossref
Crossref
Y. Baran, S. Zencir, Z. Cakir, E. Ozturk & Z. Topcu. (2011) Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition. Journal of Clinical Pharmacy and Therapeutics 36:6, pages 673-679.
Crossref
Crossref
Qun He, Jun Dong, Huanying Zhen, Yalin Ying, Jun Zhang, Qiong Li, Birong Li & Yang Zhou. (2011) A small molecule significantly inhibits the bcr/abl fusion gene at the mRNA level in human chronic myelogenous leukemia. Leukemia Research 35:8, pages 1074-1079.
Crossref
Crossref
X. Zhu, L. Wang, B. Zhang, J. Li, X. Dou & R. C. Zhao. (2011) TGF- 1-induced PI3K/Akt/NF- B/MMP9 signalling pathway is activated in Philadelphia chromosome-positive chronic myeloid leukaemia hemangioblasts. Journal of Biochemistry 149:4, pages 405-414.
Crossref
Crossref
Çığır Biray Avcı, Cumhur Gündüz, Yusuf Baran, Fahri Şahin, Sunde Yılmaz, Zeynep Ozlem Dogan & Güray Saydam. (2010) Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells. Journal of Cancer Research and Clinical Oncology 137:1, pages 41-47.
Crossref
Crossref
Yan-lin Wei, Lei Xu, Yun Liang, Xiao-hua Xu & Xiao-ying Zhao. (2009) Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo. Acta Pharmacologica Sinica 30:4, pages 451-457.
Crossref
Crossref
Baran Yusuf, Coskun Oztekin & Bassoy Esen Yonca. (2009) Inhibition of proteasome by bortezomib increase chemosensitivity of bcr/abl positive human k562 chronic myleoid leukemia cells to imatinib. Health 01:04, pages 320-324.
Crossref
Crossref